Dyb11 larvae exhibit a significant increase in the apparent patches within the SSR of Type Ib NMJ boutons, in the NMJ bouton number and in the number of nc82+ punctae per total synapses on body wall muscles 6 and 7 compared to controls.
Dyb11 heterozygous or homozygous third instar larval NMJs exhibit a significant increase in evoked junctional potential (EJC) amplitudes and mean quantal content compared to controls. Also Dyb11 third instar larval muscles 6 exhibit a significant increase in the cumulative EJC amplitude compared to controls.
Dyb11 has abnormal neurophysiology | third instar larval stage phenotype, suppressible by Cdc424
Dyb11 has abnormal neurophysiology | third instar larval stage phenotype, suppressible by Cdc42KK108698/Scer\GAL4Mhc.PU
Dyb11 is an enhancer of visible | adult stage phenotype of DysE6
Dyb11 is an enhancer of visible | adult stage phenotype of cv-c1
Dyb11 has A1-7 ventral longitudinal muscle cell | larval stage phenotype, suppressible by Cdc42KK108698/Scer\GAL4Mhc.PU
Dyb11 has A1-7 ventral longitudinal muscle cell | larval stage phenotype, suppressible by Cdc424
Dyb11 is an enhancer of posterior crossvein phenotype of DysE6
Dyb11 is an enhancer of posterior crossvein phenotype of cv-c1
Dyb11 heterozygosity or homozygosity enhances the posterior crossvein phenotype of cv-c1 or DysE6 heterozygous adults.
Cdc424 heterozygosity or expression of Cdc42KK108698 under the control of Scer\GAL4Mhc.PU suppresses the quantal content and evoked junctional potential phenotypes of Dyb11 heterozygotes.
Expression of Cdc42KK108698 under the control of Scer\GAL4Mhc.PU leads to a significant increase in the frequency of miniature evoked junctional potentials in Dyb11 heterozygous third instar larval muscle 6 compared to controls.
Dyb11 is rescued by Scer\GAL4how-24B/DybUAS.Tag:MYC
Dyb11 is not rescued by Scer\GAL4RapGAP1-OK6/DybUAS.Tag:MYC